Latest News and Press Releases

Vancouver, Canada, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Post-operative infections occur in up to 300,000 patients per year in the United States and cost the US healthcare system tens of billions of...

Vancouver, Canada, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Ondine Biomedical’s photodisinfection technology is one of the only new technologies available to economically combat drug-resistant...

Vancouver, Canada, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. (LON:OBI) has appointed Charles Young as its VP Sales & Marketing, North America to lead the commercialization of its...

Vancouver, Canada, Dec. 15, 2021 (GLOBE NEWSWIRE) -- AIM listed life sciences company, Ondine Biomedical, has appointed Professor Trevor Jones CBE FMedSci to lead a new advisory board on the use of...

Vancouver, Canada, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Canadian life sciences company, Ondine Biomedical, has appointed a new Board of Directors with considerable medtech and pharma expertise...

Vancouver, Canada, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Ondine’s nasal photodisinfection technology has been shown to eliminate the RNA signature of SARS-CoV-2, including the dominant Delta variant,...

Vancouver, Canada, Sept. 18, 2021 (GLOBE NEWSWIRE) -- Nasal decolonization is recommended by the WHO and CDC to reduce hospital acquired infections (HAIs), [1] which have been exacerbated by COVID....

Vancouver, Canada, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Ondine's technology platform is capable of painlessly and rapidly destroying a broad spectrum of bacteria, fungi, and viruses — including...

Vancouver, Canada, July 26, 2021 (GLOBE NEWSWIRE) -- Ondine’s photodisinfection technology platform uses light-activated drugs to destroy target pathogens painlessly and without building-up...

Oakville, Ontario, June 08, 2020 (GLOBE NEWSWIRE) -- Verso Surgery Centre announces that after a 1-year deployment of Steriwave™ Nasal Decolonization (Ondine Biomedical, Vancouver, BC) they have not...